98 related articles for article (PubMed ID: 3802205)
21. Antigen-specific enhancement of the human antibody response by a substituted nucleoside.
Goodman MG; Weigle WO
Adv Exp Med Biol; 1986; 195 Pt B():451-8. PubMed ID: 3490126
[No Abstract] [Full Text] [Related]
22. Protein kinase C independent restoration of specific immune responsiveness in common variable immunodeficiency.
Goodman MG; Gupta S; Rosenthale ME; Capetola RJ; Bell SC; Weigle WO
Clin Immunol Immunopathol; 1991 Apr; 59(1):26-36. PubMed ID: 2019009
[TBL] [Abstract][Full Text] [Related]
23. Immunobiologic properties of the C8-derivatized guanine ribonucleosides.
Goodman MG
Biomed Pharmacother; 1983; 37(7):344-50. PubMed ID: 6607752
[TBL] [Abstract][Full Text] [Related]
24. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines.
Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG
Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754
[TBL] [Abstract][Full Text] [Related]
25. B lymphocytes from hyporesponsive SJL mice contain aberrant nucleoside binding sites.
Goodman MG
Cell Immunol; 1990 Sep; 129(2):377-84. PubMed ID: 2383897
[TBL] [Abstract][Full Text] [Related]
26. The effect of aging on the induction of tolerance in a subpopulation of B lymphocytes.
Weigle WO; Thoman ML; Goodman MG
Cell Immunol; 1988 Jan; 111(1):253-7. PubMed ID: 2448045
[TBL] [Abstract][Full Text] [Related]
27. Large, activated B cells are the primary B-cell target of 8-bromoguanosine and 8-mercaptoguanosine.
Wicker LS; Boltz RC; Nichols EA; Miller BJ; Sigal NH; Peterson LB
Cell Immunol; 1987 May; 106(2):318-29. PubMed ID: 3494541
[TBL] [Abstract][Full Text] [Related]
28. Augmentation of the antibody response in aged mice with an 8-derivatized guanosine nucleoside and its effect on immunological memory.
Weigle WO; Thoman ML; Goodman MG
Cell Immunol; 1987 Oct; 109(2):332-7. PubMed ID: 2444346
[TBL] [Abstract][Full Text] [Related]
29. Substituted guanine ribonucleosides as B cell activators.
Gupta S; Vayuvegula B; Gollapudi S
Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 2):S21-7. PubMed ID: 1934610
[TBL] [Abstract][Full Text] [Related]
30. The immunostimulatory compound 7-allyl-8-oxoguanosine (loxoribine) induces a distinct subset of murine cytokines.
Pope BL; MacIntyre JP; Kimball E; Lee S; Zhou L; Taylor GR; Goodman MG
Cell Immunol; 1995 May; 162(2):333-9. PubMed ID: 7743561
[TBL] [Abstract][Full Text] [Related]
31. 8-Mercaptoguanosine overcomes unresponsiveness of human neonatal B cells to polysaccharide antigens.
Rijkers GT; Dollekamp I; Zegers BJ
J Immunol; 1988 Oct; 141(7):2313-6. PubMed ID: 3262655
[TBL] [Abstract][Full Text] [Related]
32. Lymphokine-activated killer (LAK) cells. V. 8-Mercaptoguanosine as an IL-2-sparing agent in LAK generation.
Thompson RA; Ballas ZK
J Immunol; 1990 Nov; 145(10):3524-31. PubMed ID: 1700014
[TBL] [Abstract][Full Text] [Related]
33. 5-Halo-6-phenyl pyrimidinones and 8-substituted guanosines: biological response modifiers with similar effects on B cells.
Wicker LS; Ashton WT; Boltz RC; Meurer LC; Miller BJ; Nichols EA; Sigal NH; Tolman RL; Peterson LB
Cell Immunol; 1988 Mar; 112(1):156-65. PubMed ID: 3257907
[TBL] [Abstract][Full Text] [Related]
34. Thiazolo[4,5-d]pyrimidine nucleosides. The synthesis of certain 3-beta-D-ribofuranosylthiazolo[4,5-d]pyrimidines as potential immunotherapeutic agents.
Nagahara K; Anderson JD; Kini GD; Dalley NK; Larson SB; Smee DF; Jin A; Sharma BS; Jolley WB; Robins RK
J Med Chem; 1990 Jan; 33(1):407-15. PubMed ID: 2153211
[TBL] [Abstract][Full Text] [Related]
35. Leishmania amazonensis infection is reduced in macrophages treated with guanine ribonucleosides.
Giorgio S; Barão SC; Augusto O; Kwee JK
Acta Trop; 1998 Jun; 70(1):119-22. PubMed ID: 9707370
[No Abstract] [Full Text] [Related]
36. Enhancement of T cell proliferation and differentiation by 8-mercaptoguanosine.
Goodman MG; Weigle WO
Adv Exp Med Biol; 1986; 195 Pt B():443-9. PubMed ID: 2945407
[No Abstract] [Full Text] [Related]
37. Loxoribine (7-allyl-8-oxoguanosine) activates natural killer cells and primes cytolytic precursor cells for activation by IL-2.
Pope BL; Chourmouzis E; Victorino L; MacIntyre JP; Capetola RJ; Lau CY
J Immunol; 1993 Sep; 151(6):3007-17. PubMed ID: 8376766
[TBL] [Abstract][Full Text] [Related]
38. 8-Hydroxyguanosine and 8-methoxyguanosine possess immunostimulating activity for B lymphocytes.
Ahmad A; Mond JJ
Cell Immunol; 1985 Aug; 94(1):276-80. PubMed ID: 3874705
[TBL] [Abstract][Full Text] [Related]
39. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY
Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674
[TBL] [Abstract][Full Text] [Related]
40. Manifold amplification of in vivo immunity in normal and immunodeficient mice by ribonucleosides derivatized at C8 of guanine.
Goodman MG; Weigle WO
Proc Natl Acad Sci U S A; 1983 Jun; 80(11):3452-5. PubMed ID: 6344084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
